Gene · 391
RHOG: ras homolog family member G
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. RHOG: ras homolog family member G. Genes, record 391. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/391
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| P84095 | Rho-related GTP-binding protein RhoG | 191 | 6 | Ensembl, GeneID, HGNC |
Source UniProt
Patents28
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| EP 4801540 A1 | 2026-09-09 | 79 | P84095 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 6438 | P84095 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 6438 | P84095 | Espacenet |
| US 11884978 B2 | 2024-01-30 | 709 | P84095 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 71822 | P84095 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 71823 | P84095 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 71824 | P84095 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 71825 | P84095 | Espacenet |
| JP 2022524081 A | 2022-04-27 | 174793 | P84095 | Espacenet |
| JP 2022524081 A | 2022-04-27 | 174794 | P84095 | Espacenet |
1 to 10 of 28
See all 28 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,420
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | RHOG papers | Newest fiscal year |
|---|---|---|---|
| T32CA009109 | Cancer Research Training Program: From Molecular Mechanisms to Therapeutic Strategies | 6 | 2025 |
| P30CA013330 | Cancer Center Support Grant | 4 | 2025 |
| P30CA016086 | Cancer Center Support Grant | 4 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 3 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 3 | 2025 |
| P30CA046934 | University of Colorado Cancer Center Support Grant | 3 | 2025 |
| P51OD011092 | Support for National Primate Research Center | 3 | 2025 |
| R35GM122596 | Dissecting signaling in vivo via precise control and visualization of protein activity | 3 | 2025 |
| R35GM136226 | Multiplex Imaging of Signaling Pathways in Cell Motility | 3 | 2025 |
| T32ES018827 | Research Training in Environmental Toxicology | 3 | 2025 |
1 to 10 of 1,420Source NIH's project files
See all 1,420 nih grantsPapers1,903
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| PKC Inhibition by Gö6976 Promotes Osteogenic Differentiation of Dental Follicle Cells Involving Rho-Dependent Pathway Dynamics. | Biomedicines | 2026 | 42652152 | PubTator, text mining | PubMed |
| α 1A-Adrenergic receptor (ADRA1A) signaling signatures as prognostic biomarkers in liver hepatocellular carcinoma: a bioinformatic analysis. | In Silico Pharmacol | 2026 | 42542688 | PubTator, text mining | PubMed |
| SGEF coordinates epithelial morphogenesis by regulating junction stability, collective migration, and extracellular matrix remodeling. | bioRxiv | 2026 | 42538976 | PubTator, text mining | PubMed |
| A Rho GTPase-related gene signature predicts prognosis and reveals an immunosuppressive microenvironment in lung adenocarcinoma: an integrated analysis of bulk and single-cell RNA sequencing data. | Sci Rep | 2026 | 42469385 | PubTator, text mining | PubMed |
| Persistence without turnover: the RhoG G12E mutant highlights the role of nucleotide cycling in RhoG signaling. | Biochem J | 2026 | 42384407 | PubTator, text mining | PubMed |
| Supercharging the metabolic engine: mitochondrial engineering strategies for CAR-T persistence in solid tumors. | Front Immunol | 2026 | 42183245 | PubTator, text mining | PubMed |
| RhoG, Rac1 and Cdc42 cooperation in cell protrusion revealed by multiplexed optogenetics and biosensor imaging. | bioRxiv | 2026 | 42182105 | PubTator, text mining | PubMed |
| Recent advances in CDC42 subfamily inhibition and therapeutic potential. | Trends Pharmacol Sci | 2026 | 42168045 | PubTator, text mining | PubMed |
| The RhoG-Binding Domain of ELMO1 Rescues the PTENopathy-like Phenotype in Oligodendroglial FBD-102b Cells. | Int J Mol Sci | 2026 | 42074101 | PubTator, text mining | PubMed |
| TBXA2R activates ERMs to drive motility, invasion, and metastatic colonization of TNBC cells. | Life Sci Alliance | 2026 | 41844278 | PubTator, text mining | PubMed |
1 to 10 of 1,903
See all 1,903 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/391
GET https://conductscience.org/api/genes/v1/391/patents?page=2